SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-081215
Filing Date
2021-06-15
Accepted
2021-06-15 08:07:58
Documents
15
Period of Report
2021-06-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2119572d1_8k.htm   iXBRL 8-K 30081
2 EXHIBIT 1.1 tm2119572d1_ex1-1.htm EX-1.1 198370
3 EXHIBIT 5.1 tm2119572d1_ex5-1.htm EX-5.1 6316
7 GRAPHIC image_001.jpg GRAPHIC 4661
  Complete submission text file 0001104659-21-081215.txt   464489

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nvax-20210615.xsd EX-101.SCH 3184
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20210615_lab.xml EX-101.LAB 34592
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20210615_pre.xml EX-101.PRE 22709
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2119572d1_8k_htm.xml XML 3483
Mailing Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 21 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26770 | Film No.: 211016932
SIC: 2836 Biological Products, (No Diagnostic Substances)